Stocks › ARQT
Arcutis Biotherapeutics, Inc.
ARQT·Nasdaq·
United States·USD
United States·USD$23.92
-1.23 (-4.89%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
ARQT
Arcutis Biotherapeutics, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ARQTS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of ARQT by members of U.S. Congress · 6 on record · 3 in the last 12 months
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.House · D · CA |
ARQTArcutis Biotherapeutics, Inc. · Stock |
Purchase $1,001 - $15,000 |
Jun 8, 2026 | May 29, 2026 | Filing ↗ |
| Gilbert Ray Cisneros, Jr.House · D · CA |
ARQTArcutis Biotherapeutics, Inc. · Stock |
Purchase $1,001 - $15,000 |
Apr 7, 2026 | Mar 3, 2026 | Filing ↗ |
| Gilbert Ray Cisneros, Jr.House · D · CA |
ARQTArcutis Biotherapeutics, Inc. · Stock |
Sale $1,001 - $15,000 |
Jan 12, 2026 | Dec 11, 2025 | Filing ↗ |
 Josh GottheimerHouse · D · NJ |
ARQTArcutis Biotherapeutics, Inc. · Stock |
Sale $1,001 - $15,000 |
Oct 15, 2023 | Sep 15, 2023 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
ARQTArcutis Biotherapeutics, Inc. · Stock |
Purchase $1,001 - $15,000 |
May 19, 2023 | Apr 17, 2023 | Filing ↗ |
| Josh GottheimerHouse · D · NJ |
ARQTArcutis Biotherapeutics, Inc. · Stock |
Purchase $1,001 - $15,000 |
Jul 22, 2022 | Jun 15, 2022 | Filing ↗ |
Whale Activity
Position changes in ARQT reported for 2026-06-30 by 10 tracked institutional filers
- Increased7
- New0
- Held0
- Decreased2
- Closed0
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 10.5M | $276.5M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.0M | $130.8M | increased |
| D. E. Shaw & Co., Inc. | 3.9M | $103.6M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.4M | $63.7M | increased |
| CITADEL ADVISORS LLC | 1.2M | $30.4M | increased |
| TWO SIGMA INVESTMENTS, LP | 663.9K | $17.4M | increased |
| MILLENNIUM MANAGEMENT LLC | 564.1K | $14.8M | increased |
| Point72 Asset Management, L.P. | 362.4K | $9.5M | decreased |
| MYDA Advisors LLC | 240.0K | $6.3M | — |
| RENAISSANCE TECHNOLOGIES LLC | 58.4K | $1.5M | decreased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by ARQT insiders, by quarter · Form 4
Recent Insider Transactions
668 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Matsuda MasaruSee Remarks | Sale | −3,674 | $25.00 | $92K | Sep 16, 2026 | Form 4 ↗ |
| Welgus Howard G.Director · Director | Sale | −4,730 | $24.18 | $114K | Sep 15, 2026 | Form 4 ↗ |
| Matsuda MasaruSee Remarks | Sale | −9,989 | $25.03 | $250K | Sep 8, 2026 | Form 4 ↗ |
| Curran TerrieDirector · Director | Sale | −27.1K | $25.03 | $677K | Aug 27, 2026 | Form 4 ↗ |
| Curran TerrieDirector · Director | Sale | −11.1K | $25.03 | $279K | Aug 27, 2026 | Form 4 ↗ |
| Curran TerrieDirector · Director | Sale | −1,072 | $26.04 | $28K | Aug 20, 2026 | Form 4 ↗ |
| Burnett PatrickSee Remarks | Sale | −1,697 | $27.00 | $46K | Aug 19, 2026 | Form 4 ↗ |
| Welgus Howard G.Director · Director | Sale | −4,730 | $26.18 | $124K | Aug 17, 2026 | Form 4 ↗ |
| Burnett PatrickSee Remarks | Sale | −6,700 | $26.08 | $175K | Aug 12, 2026 | Form 4 ↗ |
| Burnett PatrickSee Remarks | Sale | −8,300 | $26.52 | $220K | Aug 11, 2026 | Form 4 ↗ |
| Burnett PatrickSee Remarks | Sale | −955 | $26.12 | $25K | Aug 3, 2026 | Form 4 ↗ |
| Matsuda MasaruSee Remarks | Sale | −1,230 | $26.12 | $32K | Aug 3, 2026 | Form 4 ↗ |
| Watanabe ToddSee Remarks · Director | Sale | −4,375 | $26.12 | $114K | Aug 3, 2026 | Form 4 ↗ |
| Welgus Howard G.Director · Director | Sale | −4,730 | $26.91 | $127K | Jul 15, 2026 | Form 4 ↗ |
| Welgus Howard G.Director | Sale | −635 | $25.67 | $16K | Jun 17, 2026 | Form 4 ↗ |
| LIN SUE-JEANDirector | Sale | −4,946 | $24.38 | $121K | Jun 15, 2026 | Form 4 ↗ |
| Welgus Howard G.Director | Sale | −4,096 | $24.41 | $100K | Jun 15, 2026 | Form 4 ↗ |
| Welgus Howard G.Director | Option exercise | +2,255 | $8.63 | $19K | Jun 15, 2026 | Form 4 ↗ |
| Welgus Howard G.Director | Option exercise | +1,019 | $7.51 | $8K | Jun 15, 2026 | Form 4 ↗ |
| Welgus Howard G.Director | Option exercise | +822 | $6.52 | $5K | Jun 15, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding ARQT · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3.6M | $93.5M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 2.9M | $77.0M | 0.09% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 2.9M | $76.4M | 0.71% | Jun 30, 2026 |
| Small Cap Growth Fund American Century Mutual Funds, Inc. | 1.5M | $39.4M | 0.71% | Jul 31, 2026 |
| PGIM Jennison Small Company Fund Prudential Jennison Small Co Fund, Inc. | 1.4M | $36.3M | 1.04% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.3M | $34.3M | 0.04% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 1.3M | $33.6M | 0.10% | Jul 31, 2026 |
| Oberweis Small-Cap Opportunities Fund OBERWEIS FUNDS | 1.2M | $31.8M | 1.12% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF iShares Trust | 1.1M | $27.7M | 0.18% | Jun 30, 2026 |
| BARON DISCOVERY FUND BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 867.4K | $22.7M | 1.24% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list ARQT's shares (CUSIP 03969K108), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 17.8M shares14.1%
Oct 5, 2026 · ↗ - Polar Capital LLPSCHEDULE 13G · passive (13G) · 6.6M shares5.3%
Aug 14, 2026 · ↗ - Polar Capital Holdings PlcSCHEDULE 13G · passive (13G) · 6.6M shares5.3%
Aug 14, 2026 · ↗ - STATE STREET CORPORATIONSCHEDULE 13G · passive (13G) · 5.8M shares4.7%
Aug 7, 2026 · ↗ - STATE STREET CORPORATIONSCHEDULE 13G · passive (13G) · 6.3M shares5.1%
May 12, 2026 · ↗ - PRUDENTIAL FINANCIAL INCSCHEDULE 13G/A · passive (13G) · 5.3M shares4.3%
May 8, 2026 · ↗ - Jennison Associates LLCSCHEDULE 13G/A · passive (13G) · 5.0M shares4.0%
May 6, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming arcutis biotherapeutics as client
- JEFFREY J. KIMBELL & ASSOCIATES, INC.ARCUTIS BIOTHERAPEUTICS, INC. · 2026 Q3 · TAR—
Filing ↗
Government Contracts
Federal awards to Arcutis Biotherapeutics, Inc. · USAspending
No federal contract awards found for Arcutis Biotherapeutics, Inc..
U.S. Patents
Recent USPTO applications naming Arcutis Biotherapeutics, Inc.
No USPTO patent applications found for Arcutis Biotherapeutics, Inc..
Annual Financials
From ARQT's 10-K filings · XBRL
No annual XBRL figures on record for ARQT. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in ARQT's price history.
Material Events (8-K)
Corporate events filed with the SEC
About Arcutis Biotherapeutics, Inc.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersWESTLAKE VILLAGE, CA
IncorporatedDE
SEC CIK0001787306 ↗
Former namesArcutis, Inc.